Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-01-07 @ 4:19 AM
Study NCT ID:
NCT05433194
Status:
UNKNOWN
Last Update Posted:
2023-02-08
First Post:
2022-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)
Sponsor:
Suzhou Abogen Biosciences Co., Ltd.
Organization: